Murphy & Mullick Capital Management’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Murphy & Mullick Capital Management's ALAB Position: Q2 2026 in Review
Murphy & Mullick Capital Management increased its Astera Labs (ALAB) stake by 2% in Q2 2026, buying an estimated $2.12K and bringing the position to 402 shares worth $194K. The position accounts for 0.12% of the portfolio, ranked #142.
Murphy & Mullick Capital Management first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Murphy & Mullick Capital Management held 402 shares of Astera Labs worth $194K as of Q2 2026.
- Murphy & Mullick Capital Management bought 8 Astera Labs shares in Q2 2026, an estimated $2.12K.
- Astera Labs made up 0.12% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #142 holding.
- Murphy & Mullick Capital Management first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
- 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.